{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:18Z","timestamp":1791994578996,"version":"4.4.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR 2497 TP6 to FV"],"award-info":[{"award-number":["FOR 2497 TP6 to FV"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR 2497 TP5 to JW"],"award-info":[{"award-number":["FOR 2497 TP5 to JW"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","award":["F\u00f6rderprogramm f\u00fcr Forschung und Lehre (F\u00f6FoLe)"],"award-info":[{"award-number":["F\u00f6rderprogramm f\u00fcr Forschung und Lehre (F\u00f6FoLe)"]}],"id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pemphigus vulgaris is a life-threatening blistering skin disease caused by autoantibodies destabilizing desmosomal adhesion. Current therapies focus on suppression of autoantibody formation and thus treatments directly stabilizing keratinocyte adhesion would fulfill an unmet medical need. We here demonstrate that apremilast, a phosphodiesterase 4 inhibitor used in psoriasis, prevents skin blistering in pemphigus vulgaris. Apremilast abrogates pemphigus autoantibody-induced loss of keratinocyte cohesion in ex-vivo human epidermis, cultured keratinocytes in vitro and in vivo in mice. In parallel, apremilast inhibits keratin retraction as well as desmosome splitting, induces phosphorylation of plakoglobin at serine 665 and desmoplakin assembly into desmosomal plaques. We established a plakoglobin phospho-deficient mouse model that reveals fragile epidermis with altered organization of keratin filaments and desmosomal cadherins. In keratinocytes derived from these mice, intercellular adhesion is impaired and not rescued by apremilast. These data identify an unreported mechanism of desmosome regulation and propose that apremilast stabilizes keratinocyte adhesion and is protective in pemphigus.<\/jats:p>","DOI":"10.1038\/s41467-022-35741-0","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:06:00Z","timestamp":1673222760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-9617","authenticated-orcid":false,"given":"Anna M.","family":"Sigmund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-7955","authenticated-orcid":false,"given":"Markus","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Engelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kugelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn T.","family":"Egu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letyfee S.","family":"Steinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-6517","authenticated-orcid":false,"given":"Matthias","family":"Hiermaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya Y.","family":"Radeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska C.","family":"Bayerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Butz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kotschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hudemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-2023","authenticated-orcid":false,"given":"Sunil","family":"Yeruva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-8913","authenticated-orcid":false,"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir S.","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5526-7517","authenticated-orcid":false,"given":"Kamran","family":"Ghoreschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8570-7595","authenticated-orcid":false,"given":"Franziska","family":"Vielmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-5422","authenticated-orcid":false,"given":"Jens","family":"Waschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"35741_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00441-015-2136-5","volume":"360","author":"JA Broussard","year":"2015","unstructured":"Broussard, J. A., Getsios, S. & Green, K. J. Desmosome regulation and signaling in disease. Cell Tissue Res. 360, 501\u2013512 (2015).","journal-title":"Cell Tissue Res."},{"key":"35741_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.bbamem.2007.07.014","volume":"1778","author":"D Garrod","year":"2008","unstructured":"Garrod, D. & Chidgey, M. Desmosome structure, composition and function. Biochim. Biophys. Acta 1778, 572\u2013587 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"35741_CR3","doi-asserted-by":"publisher","unstructured":"Green, K. J., Jaiganesh, A. & Broussard, J. A. Desmosomes: essential contributors to an integrated intercellular junction network. F1000Res https:\/\/doi.org\/10.12688\/f1000research.20942.1 (2019).","DOI":"10.12688\/f1000research.20942.1"},{"key":"35741_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.aanat.2018.11.006","volume":"226","author":"J Waschke","year":"2019","unstructured":"Waschke, J. Desmogleins as signaling hubs regulating cell cohesion and tissue\/organ function in skin and heart - EFEM lecture 2018. Ann. Anat. 226, 96\u2013100 (2019).","journal-title":"Ann. Anat."},{"key":"35741_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","volume":"394","author":"E Schmidt","year":"2019","unstructured":"Schmidt, E., Kasperkiewicz, M. & Joly, P. Pemphigus. Lancet 394, 882\u2013894 (2019).","journal-title":"Lancet"},{"key":"35741_CR6","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","volume":"3","author":"M Kasperkiewicz","year":"2017","unstructured":"Kasperkiewicz, M. et al. Pemphigus. Nat. Rev. Dis. Prim. 3, 17026 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"35741_CR7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3389\/fimmu.2018.01190","volume":"9","author":"KT Amber","year":"2018","unstructured":"Amber, K. T., Valdebran, M. & Grando, S. A. Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris. Front. Immunol. 9, 1190 (2018).","journal-title":"Front. Immunol."},{"key":"35741_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fimmu.2018.00136","volume":"9","author":"V Spindler","year":"2018","unstructured":"Spindler, V. & Waschke, J. Pemphigus-A disease of desmosome dysfunction caused by multiple mechanisms. Front. Immunol. 9, 136 (2018).","journal-title":"Front. Immunol."},{"key":"35741_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jid.2017.06.022","volume":"138","author":"V Spindler","year":"2018","unstructured":"Spindler, V. et al. Mechanisms causing loss of keratinocyte cohesion in pemphigus. J. Invest. Dermatol. 138, 32\u201337 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fimmu.2018.00692","volume":"9","author":"T Sajda","year":"2018","unstructured":"Sajda, T. & Sinha, A. A. Autoantibody signaling in pemphigus vulgaris: development of an integrated model. Front. Immunol. 9, 692 (2018).","journal-title":"Front. Immunol."},{"key":"35741_CR11","doi-asserted-by":"publisher","unstructured":"Schmitt, T. & Waschke, J. Autoantibody-specific signalling in pemphigus. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2021.701809 (2021).","DOI":"10.3389\/fmed.2021.701809"},{"key":"35741_CR12","doi-asserted-by":"publisher","unstructured":"Schmitt, T. et al. Ca(2+) signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus. Br. J. Dermatol. https:\/\/doi.org\/10.1111\/bjd.20091 (2021).","DOI":"10.1111\/bjd.20091"},{"key":"35741_CR13","first-page":"800","volume":"123","author":"V Spindler","year":"2013","unstructured":"Spindler, V. et al. Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering. J. Clin. Invest. 123, 800\u2013811 (2013).","journal-title":"J. Clin. Invest."},{"key":"35741_CR14","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.3389\/fimmu.2019.02883","volume":"10","author":"DT Egu","year":"2019","unstructured":"Egu, D. T., Kugelmann, D. & Waschke, J. Role of PKC and ERK signaling in epidermal blistering and desmosome regulation in pemphigus. Front. Immunol. 10, 2883 (2019).","journal-title":"Front. Immunol."},{"key":"35741_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fimmu.2019.00626","volume":"10","author":"D Kugelmann","year":"2019","unstructured":"Kugelmann, D. et al. Role of Src and cortactin in pemphigus skin blistering. Front. Immunol. 10, 626 (2019).","journal-title":"Front. Immunol."},{"key":"35741_CR16","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3389\/fimmu.2019.01128","volume":"10","author":"E Walter","year":"2019","unstructured":"Walter, E. et al. Role of Dsg1- and Dsg3-mediated signaling in pemphigus autoantibody-induced loss of keratinocyte cohesion. Front. Immunol. 10, 1128 (2019).","journal-title":"Front. Immunol."},{"key":"35741_CR17","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1111\/bph.15233","volume":"177","author":"IAK Burmester","year":"2020","unstructured":"Burmester, I. A. K. et al. Identification of novel therapeutic targets for blocking acantholysis in pemphigus. Br. J. Pharmacol. 177, 5114\u20135130 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"35741_CR18","doi-asserted-by":"publisher","first-page":"12855","DOI":"10.1073\/pnas.0602973103","volume":"103","author":"P Berkowitz","year":"2006","unstructured":"Berkowitz, P. et al. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc. Natl Acad. Sci. USA 103, 12855\u201312860 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35741_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.18382","volume":"182","author":"M Ivars","year":"2020","unstructured":"Ivars, M. et al. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient. Br. J. Dermatol. 182, 1194\u20131204 (2020).","journal-title":"Br. J. Dermatol."},{"key":"35741_CR20","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.4049\/jimmunol.1002675","volume":"185","author":"V Spindler","year":"2010","unstructured":"Spindler, V., Vielmuth, F., Schmidt, E., Rubenstein, D. S. & Waschke, J. Protective endogenous cyclic adenosine 5\u2019-monophosphate signaling triggered by pemphigus autoantibodies. J. Immunol. 185, 6831\u20136838 (2010).","journal-title":"J. Immunol."},{"key":"35741_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/CIRCRESAHA.116.309631","volume":"120","author":"C Schinner","year":"2017","unstructured":"Schinner, C. et al. Adrenergic signaling strengthens cardiac myocyte cohesion. Circ. Res. 120, 1305\u20131317 (2017).","journal-title":"Circ. Res."},{"key":"35741_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fphys.2020.00430","volume":"11","author":"S Yeruva","year":"2020","unstructured":"Yeruva, S. et al. Adrenergic signaling-induced ultrastructural strengthening of intercalated discs via plakoglobin is crucial for positive adhesiotropy in murine cardiomyocytes. Front. Physiol. 11, 430 (2020).","journal-title":"Front. Physiol."},{"key":"35741_CR23","doi-asserted-by":"publisher","first-page":"e92021","DOI":"10.1172\/jci.insight.92021","volume":"2","author":"CT Ellebrecht","year":"2017","unstructured":"Ellebrecht, C. T. & Payne, A. S. Setting the target for pemphigus vulgaris therapy. JCI Insight 2, e92021 (2017).","journal-title":"JCI Insight"},{"key":"35741_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-017-8662-z","volume":"54","author":"R Pollmann","year":"2018","unstructured":"Pollmann, R., Schmidt, T., Eming, R. & Hertl, M. Pemphigus: a comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches. Clin. Rev. Allergy Immunol. 54, 1\u201325 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"35741_CR25","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3389\/fimmu.2019.01418","volume":"10","author":"D Didona","year":"2019","unstructured":"Didona, D., Maglie, R., Eming, R. & Hertl, M. Pemphigus: current and future therapeutic strategies. Front. Immunol. 10, 1418 (2019).","journal-title":"Front. Immunol."},{"key":"35741_CR26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1046\/j.1365-2141.2002.03753.x","volume":"118","author":"BT Heelan","year":"2002","unstructured":"Heelan, B. T. et al. Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. Br. J. Haematol. 118, 1078\u20131081 (2002).","journal-title":"Br. J. Haematol."},{"key":"35741_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.12688\/f1000research.9476.1","volume":"6","author":"NA Ran","year":"2017","unstructured":"Ran, N. A. & Payne, A. S. Rituximab therapy in pemphigus and other autoantibody-mediated diseases. F1000Res 6, 83 (2017).","journal-title":"F1000Res"},{"key":"35741_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fimmu.2018.00622","volume":"9","author":"P Musette","year":"2018","unstructured":"Musette, P. & Bouaziz, J. D. B cell modulation strategies in autoimmune diseases: new concepts. Front. Immunol. 9, 622 (2018).","journal-title":"Front. Immunol."},{"key":"35741_CR29","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/jdv.16752","volume":"34","author":"P Joly","year":"2020","unstructured":"Joly, P. et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). J. Eur. Acad. Dermatol Venereol. 34, 1900\u20131913 (2020).","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"35741_CR30","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jaad.2017.11.056","volume":"78","author":"R Zebda","year":"2018","unstructured":"Zebda, R. & Paller, A. S. Phosphodiesterase 4 inhibitors. J. Am. Acad. Dermatol. 78, S43\u2013S52 (2018).","journal-title":"J. Am. Acad. Dermatol."},{"key":"35741_CR31","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","volume":"9","author":"H Li","year":"2018","unstructured":"Li, H., Zuo, J. & Tang, W. Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases. Front. Pharmacol. 9, 1048 (2018).","journal-title":"Front. Pharmacol."},{"key":"35741_CR32","first-page":"835","volume":"17","author":"C Pincelli","year":"2018","unstructured":"Pincelli, C., Schafer, P. H., French, L. E., Augustin, M. & Krueger, J. G. Mechanisms underlying the clinical effects of apremilast for psoriasis. J. Drugs Dermatol. 17, 835\u2013840 (2018).","journal-title":"J. Drugs Dermatol."},{"key":"35741_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40257-017-0302-0","volume":"19","author":"T Torres","year":"2018","unstructured":"Torres, T. & Puig, L. Apremilast: a novel oral treatment for psoriasis and psoriatic arthritis. Am. J. Clin. Dermatol 19, 23\u201332 (2018).","journal-title":"Am. J. Clin. Dermatol"},{"key":"35741_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40265-017-0709-1","volume":"77","author":"GM Keating","year":"2017","unstructured":"Keating, G. M. Apremilast: a review in psoriasis and psoriatic arthritis. Drugs 77, 459\u2013472 (2017).","journal-title":"Drugs"},{"key":"35741_CR35","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","volume":"381","author":"G Hatemi","year":"2019","unstructured":"Hatemi, G. et al. Trial of apremilast for oral ulcers in Behcet\u2019s syndrome. N. Engl. J. Med. 381, 1918\u20131928 (2019).","journal-title":"N. Engl. J. Med."},{"key":"35741_CR36","doi-asserted-by":"publisher","first-page":"588315","DOI":"10.3389\/fimmu.2020.588315","volume":"11","author":"K Meier","year":"2020","unstructured":"Meier, K., Holstein, J., Solimani, F., Waschke, J. & Ghoreschi, K. Case report: apremilast for therapy-resistant pemphigus vulgaris. Front. Immunol. 11, 588315 (2020).","journal-title":"Front. Immunol."},{"key":"35741_CR37","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2353\/ajpath.2007.070028","volume":"171","author":"V Spindler","year":"2007","unstructured":"Spindler, V., Drenckhahn, D., Zillikens, D. & Waschke, J. Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3. Am. J. Pathol. 171, 906\u2013916 (2007).","journal-title":"Am. J. Pathol."},{"key":"35741_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1172\/JCI5252","volume":"103","author":"MG Mahoney","year":"1999","unstructured":"Mahoney, M. G. et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J. Clin. Invest. 103, 461\u2013468 (1999).","journal-title":"J. Clin. Invest."},{"key":"35741_CR39","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.0022-202X.2004.22426.x","volume":"122","author":"A Shimizu","year":"2004","unstructured":"Shimizu, A. et al. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J. Invest. Dermatol. 122, 1145\u20131153 (2004).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/JID.2015.353","volume":"136","author":"SN Stahley","year":"2016","unstructured":"Stahley, S. N. et al. Super-resolution microscopy reveals altered desmosomal protein organization in tissue from patients with pemphigus vulgaris. J. Invest. Dermatol. 136, 59\u201366 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR41","doi-asserted-by":"publisher","first-page":"e50696","DOI":"10.1371\/journal.pone.0050696","volume":"7","author":"M Saito","year":"2012","unstructured":"Saito, M. et al. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS ONE 7, e50696 (2012).","journal-title":"PLoS ONE"},{"key":"35741_CR42","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/jid.2014.140","volume":"134","author":"G van der Wier","year":"2014","unstructured":"van der Wier, G., Pas, H. H., Kramer, D., Diercks, G. F. H. & Jonkman, M. F. Smaller desmosomes are seen in the skin of pemphigus patients with anti-desmoglein 1 antibodies but not in patients with anti-desmoglein 3 antibodies. J. Invest. Dermatol. 134, 2287\u20132290 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR43","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/jid.2015.109","volume":"135","author":"E Sokol","year":"2015","unstructured":"Sokol, E. et al. Large-scale electron microscopy maps of patient skin and mucosa provide insight into pathogenesis of blistering diseases. J. Invest. Dermatol. 135, 1763\u20131770 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR44","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1242\/jcs.185785","volume":"129","author":"SN Stahley","year":"2016","unstructured":"Stahley, S. N., Bartle, E. I., Atkinson, C. E., Kowalczyk, A. P. & Mattheyses, A. L. Molecular organization of the desmosome as revealed by direct stochastic optical reconstruction microscopy. J. Cell Sci. 129, 2897\u20132904 (2016).","journal-title":"J. Cell Sci."},{"key":"35741_CR45","doi-asserted-by":"publisher","unstructured":"Egu, D. T., Walter, E., Spindler, V. & Waschke, J. Inhibition of p38MAPK signaling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis. Br. J. Dermatol. https:\/\/doi.org\/10.1111\/bjd.15721 (2017).","DOI":"10.1111\/bjd.15721"},{"key":"35741_CR46","doi-asserted-by":"publisher","first-page":"23778","DOI":"10.1074\/jbc.M501365200","volume":"280","author":"P Berkowitz","year":"2005","unstructured":"Berkowitz, P. et al. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J. Biol. Chem. 280, 23778\u201323784 (2005).","journal-title":"J. Biol. Chem."},{"key":"35741_CR47","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fimmu.2018.00858","volume":"9","author":"E Schlogl","year":"2018","unstructured":"Schlogl, E. et al. Keratin retraction and desmoglein3 internalization independently contribute to autoantibody-induced cell dissociation in pemphigus vulgaris. Front. Immunol. 9, 858 (2018).","journal-title":"Front. Immunol."},{"key":"35741_CR48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fimmu.2018.00528","volume":"9","author":"F Vielmuth","year":"2018","unstructured":"Vielmuth, F. et al. Keratins regulate p38MAPK-dependent desmoglein binding properties in pemphigus. Front. Immunol. 9, 528 (2018).","journal-title":"Front. Immunol."},{"key":"35741_CR49","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","volume":"170","author":"K Tsunoda","year":"2003","unstructured":"Tsunoda, K. et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J. Immunol. 170, 2170\u20132178 (2003).","journal-title":"J. Immunol."},{"key":"35741_CR50","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1083\/jcb.153.4.823","volume":"153","author":"R Caldelari","year":"2001","unstructured":"Caldelari, R. et al. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J. Cell Biol. 153, 823\u2013834 (2001).","journal-title":"J. Cell Biol."},{"key":"35741_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1523-1747.1999.00463.x","volume":"112","author":"Y Aoyama","year":"1999","unstructured":"Aoyama, Y. & Kitajima, Y. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J. Invest. Dermatol. 112, 67\u201371 (1999).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR52","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1038\/jid.2015.324","volume":"135","author":"F Vielmuth","year":"2015","unstructured":"Vielmuth, F., Waschke, J. & Spindler, V. Loss of desmoglein binding is not sufficient for keratinocyte dissociation in pemphigus. J. Invest. Dermatol. 135, 3068\u20133077 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR53","doi-asserted-by":"publisher","first-page":"30556","DOI":"10.1074\/jbc.M109.024810","volume":"284","author":"V Spindler","year":"2009","unstructured":"Spindler, V. et al. Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus. J. Biol. Chem. 284, 30556\u201330564 (2009).","journal-title":"J. Biol. Chem."},{"key":"35741_CR54","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fimmu.2019.01387","volume":"10","author":"R Lotti","year":"2019","unstructured":"Lotti, R. et al. Development of a desmocollin-3 active mouse model recapitulating human atypical pemphigus. Front. Immunol. 10, 1387 (2019).","journal-title":"Front. Immunol."},{"key":"35741_CR55","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jid.2021.06.017","volume":"142","author":"C Hudemann","year":"2022","unstructured":"Hudemann, C. et al. Human desmocollin 3-Specific IgG antibodies are pathogenic in a humanized HLA class II transgenic mouse model of pemphigus. J. Invest. Dermatol. 142, 915\u2013923 e913 (2022).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jid.2017.08.033","volume":"138","author":"F Vielmuth","year":"2018","unstructured":"Vielmuth, F. et al. Keratins regulate the adhesive properties of desmosomal cadherins through signaling. J. Invest. Dermatol. 138, 121\u2013131 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.nano.2014.10.006","volume":"11","author":"F Vielmuth","year":"2015","unstructured":"Vielmuth, F., Hartlieb, E., Kugelmann, D., Waschke, J. & Spindler, V. Atomic force microscopy identifies regions of distinct desmoglein 3 adhesive properties on living keratinocytes. Nanomedicine 11, 511\u2013520 (2015).","journal-title":"Nanomedicine"},{"key":"35741_CR58","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/jid.1961.58","volume":"36","author":"GF Wilgram","year":"1961","unstructured":"Wilgram, G. F., Caulfield, J. B. & Lever, W. F. An electron microscopic study of acantholysis in pemphigus vulgaris. J. Invest. Dermatol. 36, 373\u2013382 (1961).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR59","doi-asserted-by":"publisher","unstructured":"Radeva, M. Y. & Waschke, J. Mind the gap: mechanisms regulating the endothelial barrier. Acta Physiol. (Oxf) https:\/\/doi.org\/10.1111\/apha.12860 (2018).","DOI":"10.1111\/apha.12860"},{"key":"35741_CR60","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1083\/jcb.200605125","volume":"175","author":"J Waschke","year":"2006","unstructured":"Waschke, J. et al. Inhibition of Rho A activity causes pemphigus skin blistering. J. Cell Biol. 175, 721\u2013727 (2006).","journal-title":"J. Cell Biol."},{"key":"35741_CR61","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1083\/jcb.201208162","volume":"201","author":"C Kroger","year":"2013","unstructured":"Kroger, C. et al. Keratins control intercellular adhesion involving PKC-alpha-mediated desmoplakin phosphorylation. J. Cell Biol. 201, 681\u2013692 (2013).","journal-title":"J. Cell Biol."},{"key":"35741_CR62","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/01.RES.0000215564.22445.7e","volume":"98","author":"R Fischmeister","year":"2006","unstructured":"Fischmeister, R. Is cAMP good or bad? Depends on where it\u2019s made. Circ. Res. 98, 582\u2013584 (2006).","journal-title":"Circ. Res."},{"key":"35741_CR63","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1083\/jcb.200510038","volume":"171","author":"LM Godsel","year":"2005","unstructured":"Godsel, L. M. et al. Desmoplakin assembly dynamics in four dimensions: multiple phases differentially regulated by intermediate filaments and actin. J. Cell Biol. 171, 1045\u20131059 (2005).","journal-title":"J. Cell Biol."},{"key":"35741_CR64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tcb.2013.06.004","volume":"23","author":"O Nekrasova","year":"2013","unstructured":"Nekrasova, O. & Green, K. J. Desmosome assembly and dynamics. Trends Cell Biol. 23, 537\u2013546 (2013).","journal-title":"Trends Cell Biol."},{"key":"35741_CR65","doi-asserted-by":"publisher","unstructured":"Simard, M. et al. A tissue-engineered human psoriatic skin model to investigate the implication of cAMP in psoriasis: differential impacts of cholera toxin and isoproterenol on camp levels of the epidermis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21155215 (2020).","DOI":"10.3390\/ijms21155215"},{"key":"35741_CR66","first-page":"1065","volume":"134","author":"H Takahashi","year":"1996","unstructured":"Takahashi, H., Kinouchi, M., Tamura, T. & Iizuka, H. Decreased beta 2-adrenergic receptor-mRNA and loricrin-mRNA, and increased involucrin-mRNA transcripts in psoriatic epidermis: analysis by reverse transcription-polymerase chain reaction. Br. J. Dermatol. 134, 1065\u20131069 (1996).","journal-title":"Br. J. Dermatol."},{"key":"35741_CR67","first-page":"21","volume":"11","author":"M Milakovic","year":"2021","unstructured":"Milakovic, M. & Gooderham, M. J. Phosphodiesterase-4 inhibition in psoriasis. Psoriasis (Auckl.) 11, 21\u201329 (2021).","journal-title":"Psoriasis (Auckl.)"},{"key":"35741_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","volume":"73","author":"K Papp","year":"2015","unstructured":"Papp, K. et al. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). J. Am. Acad. Dermatol. 73, 37\u201349 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"key":"35741_CR69","first-page":"226","volume":"26","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Pemphigus associated with psoriasis vulgaris: a retrospective study of seven patients and a review of the literature. Acta Dermatovenerol. Croat. 26, 226\u2013232 (2018).","journal-title":"Acta Dermatovenerol. Croat."},{"key":"35741_CR70","doi-asserted-by":"publisher","unstructured":"Balighi, K., Daneshpazhooh, M., Mahmoudi, H. & Tavakolpour, S. Switching from pemphigus vulgaris to psoriasis: a rare report of three cases. Int. J. Dermatol. https:\/\/doi.org\/10.1111\/ijd.14823 (2020).","DOI":"10.1111\/ijd.14823"},{"key":"35741_CR71","doi-asserted-by":"publisher","first-page":"adv00293","DOI":"10.2340\/00015555-3607","volume":"100","author":"K Kridin","year":"2020","unstructured":"Kridin, K., Ludwig, R. J., Damiani, G. & Cohen, A. D. Increased risk of pemphigus among patients with psoriasis: a large-scale cohort study. Acta Derm. Venereol. 100, adv00293 (2020).","journal-title":"Acta Derm. Venereol."},{"key":"35741_CR72","doi-asserted-by":"publisher","first-page":"adv00437-6049","DOI":"10.2340\/00015555-3805","volume":"101","author":"K Nakajima","year":"2021","unstructured":"Nakajima, K, Nakajima R, Morisaka H, Nakajima H, & Sano S, Beneficial Impact of Apremilast on Palmoplantar Keratodermas. Acta Derm Venereol. 101, adv00437-6049 (2021).","journal-title":"Acta Derm Venereol."},{"key":"35741_CR73","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.106.3.761","volume":"106","author":"P Boukamp","year":"1988","unstructured":"Boukamp, P. et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761\u2013771 (1988).","journal-title":"J. Cell Biol."},{"key":"35741_CR74","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3389\/fimmu.2019.00770","volume":"10","author":"MY Radeva","year":"2019","unstructured":"Radeva, M. Y. et al. ST18 enhances PV-IgG-induced loss of keratinocyte cohesion in parallel to increased ERK activation. Front. Immunol. 10, 770 (2019).","journal-title":"Front. Immunol."},{"key":"35741_CR75","doi-asserted-by":"publisher","first-page":"581370","DOI":"10.3389\/fimmu.2020.581370","volume":"11","author":"AM Sigmund","year":"2020","unstructured":"Sigmund, A. M. et al. Dsg2 upregulation as a rescue mechanism in pemphigus. Front. Immunol. 11, 581370 (2020).","journal-title":"Front. Immunol."},{"key":"35741_CR76","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.4049\/jimmunol.181.3.1825","volume":"181","author":"WM Heupel","year":"2008","unstructured":"Heupel, W. M., Zillikens, D., Drenckhahn, D. & Waschke, J. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J. Immunol. 181, 1825\u20131834 (2008).","journal-title":"J. Immunol."},{"key":"35741_CR77","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1111\/bjd.15721","volume":"177","author":"DT Egu","year":"2017","unstructured":"Egu, D. T., Walter, E., Spindler, V. & Waschke, J. Inhibition of p38MAPK signalling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis. Br. J. Dermatol 177, 1612\u20131618 (2017).","journal-title":"Br. J. Dermatol"},{"key":"35741_CR78","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bjd.18237","volume":"182","author":"DT Egu","year":"2020","unstructured":"Egu, D. T. et al. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus. Br. J. Dermatol. 182, 987\u2013994 (2020).","journal-title":"Br. J. Dermatol."},{"key":"35741_CR79","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1073\/pnas.76.7.3116","volume":"76","author":"J Renart","year":"1979","unstructured":"Renart, J., Reiser, J. & Stark, G. R. Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc. Natl Acad. Sci. USA 76, 3116\u20133120 (1979).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35741_CR80","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","volume":"76","author":"H Towbin","year":"1979","unstructured":"Towbin, H., Staehelin, T. & Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 4350\u20134354 (1979).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35741_CR81","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1021\/bc070030s","volume":"18","author":"A Ebner","year":"2007","unstructured":"Ebner, A. et al. A new, simple method for linking of antibodies to atomic force microscopy tips. Bioconjug. Chem. 18, 1176\u20131184 (2007).","journal-title":"Bioconjug. Chem."},{"key":"35741_CR82","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jid.2020.09.022","volume":"141","author":"M Hiermaier","year":"2021","unstructured":"Hiermaier, M. et al. The actin-binding protein alpha-adducin modulates desmosomal turnover and plasticity. J. Invest. Dermatol. 141, 1219\u20131229.e1211 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"35741_CR83","doi-asserted-by":"publisher","unstructured":"Fuchs, M. et al. Plakophilin 1 but not plakophilin 3 regulates desmoglein clustering. Cell. Mol. Life Sci. https:\/\/doi.org\/10.1007\/s00018-019-03083-8 (2019).","DOI":"10.1007\/s00018-019-03083-8"}],"updated-by":[{"DOI":"10.1038\/s41467-023-36464-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35741-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T16:42:58Z","timestamp":1728664978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35741-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35741"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35741-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.07.478931","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-023-36464-6","URL":"https:\/\/doi.org\/10.1038\/s41467-023-36464-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}